The top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 2004 [electronic resource] / Marie N. Stagnitti.
Imprint
[Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2007]
Mode of access: Internet from the MEPS AHRQ web site. Address as of 9/15/2008: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st186/stat186.pdf; current access available via PURL.
Note
Title from title screen (viewed Sept. 15, 2008).
"September 2007."
"The estimates in this brief are derived from the Household Component of the 2004 Medical Expenditure Panel Survey (MEPS-HC)"--P. [1].
Summary
This statistical brief provides information on the top five outpatient prescription medicines ranked by total expenditures and insurance status for the Medicare population, as reported by households in the U.S. civilian noninstitutionalized (community) population in calendar year 2004. This brief also provides information on average total payments and average out-of-pocket payments per purchase for the top five drugs for Medicare beneficiaries, by insurance status.